Skip to main content
MPT logo

MPT · Medical Properties Trust Inc

Track MPT — free
$4.16 +0.14 (+3.48%) At close · Aug 19
Market Cap
$2.42B
Shares
598.10M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$4.16 Open$4.03 Day$4.03–4.20 52W close$4.02–6.02 Avg vol 30d6.9M Short int144.3M · 24.1% float · 30.8d Short vol50% Last earningsAug 10, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 10

Up next

Next earnings call
Nov 15, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Aug 10, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Strong Sell Momentum Very Weak Sentiment Bearish Fundamentals Fair Quant / Vol Moderate
      Market backdrop VIX 14.9 · calm Equity put/call 0.52
      Technical
      price trend
      Strong Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −17%
      below
      Price vs 50-day avg −9%
      below
      RSI (14) 39
      neutral
      MACD trend Negative
      52-week position 7%
      near low
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Weak
      1-month return −14%
      trailing
      6-month return −28%
      trailing
      YTD return −17%
      this year
      Relative strength −40%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bearish
      Trend (MA cross) No cross
      50d $5 › 200d $5 — 200d above 50d
      Institutional flow Distributing
      -2% holders QoQ · +51 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      24.12% of float · ▲ +4.4% MoM · 30.8 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      493 holders — mid 3-yr range
      Squeeze score 71
      high risk · 0–100
      Fundamentals
      Fair
      Revenue growth −2%
      Y/Y
      EPS growth +89%
      Y/Y
      Buyback $150.0M
      authorized
      Balance sheet $9.2B
      net debt
      Quant / Vol
      risk profile
      Moderate
      Volatility 38%
      annualized · 1-yr
      Max drawdown −33%
      past year
      ATR 3.8%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the Earnings Call filed Dec 31, 2025
      Annualized cash rent · by year-end at least $1B
      Prior guidance period ended · from the 8-K filed Aug 8, 2023
      Per share net income · 2023 calendar year $0.33 – $0.37
      Per share NFFO · 2023 calendar year $1.53 – $1.57

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Strong Sell
      4 · 3 · 0
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −17% Bearish
      Price vs 50-day avg
      −9% Bearish
      RSI (14)
      39 Neutral
      MACD trend
      Negative Bearish
      52-week position
      7% Bearish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $5 › 200d $5 — 200d above 50d
      Institutional flow Distributing
      -2% holders QoQ · +51 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      24.12% of float · ▲ +4.4% MoM · 30.8 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      493 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $4 Now $4 · 7% Range high $6
      vs 200-day avg -17% vs 50-day avg -9%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      countries 9 As of June 30, 2026
      Financial Leverage 59.6% As of June 30, 2026
      Funds from operations non-GAAP $207.37M Six Months Ended June 30, 2026
      hospital operating companies 51 As of June 30, 2026
      Licensed beds 38,000 As of June 30, 2026
      Normalized FFO non-GAAP $92.2M the 2026 second quarter filing
      Normalized FFO per diluted share non-GAAP $0.15 the 2026 second quarter filing
      Normalized funds from operations non-GAAP $174.46M Six Months Ended June 30, 2026
      properties 373 As of June 30, 2026
      U.S. states 30 As of June 30, 2026
      NFFO per share non-GAAP $0.14 the first quarter ended March 31, 2026

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      REIT - Healthcare Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      MPT
      Medical Properties Trust Inc
      this stock
      $2.42B -16.8% -2.4% 24.1%
      WELL
      Welltower Inc.
      $166.20B +27.0% +35.6% 117.1 2.5%
      VTR
      Ventas, Inc.
      $46.78B +18.7% +18.5% 168.9 4.6%
      DOC
      Healthpeak Properties, Inc.
      $14.24B +29.1% +4.5% 59.0 3.5%
      OHI
      Omega Healthcare Investors Inc
      $14.11B +5.8% +13.2% 16.6 4.2%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      493
      % held
      64.0%
      Net QoQ
      +14.0M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      245
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      144.3M
      Days to cover
      30.8d
      Change
      +6.0M sh
      View
      Short Volume
      Short vol %
      50%
      As of
      Aug 19, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      1.7K
      Value
      $7.8K
      As of
      Jul 31, 2026
      View
      Off-Exchange
      Off-exchange %
      51.8%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $972.0M
      Net income (FY)
      $-277.0M
      EPS diluted
      $-0.46
      View
      Buybacks
      Authorized
      $150.0M
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 10, 2026
      This year
      10
      View
      Proposed Sales
      Value
      $300.9K
      Shares
      59.0K
      Filed
      Nov 19, 2025
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 10, 2026
      View
      Investor Relations
      Latest news
      MPT Declares Regular Quarterly Di…
      Published
      Aug 13, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      MPT +2.7% -13.5% -28.4% -10.2% -16.8%
      SPY -0.4% +2.9% +11.6% +3.0% +12.8%
      vs SPY +3.2% -16.4% -40.0% -13.1% -29.6%

      Capital returns

      Latest dividend
      $0.09 / share · ex Jun 18, 2026
      Declared · upcoming
      $0.09 / share · ex Sep 10, 2026
      Raised 12.5%
      Paid (TTM)
      $0.35 / share · 4 payouts
      Dividend yield (TTM, derived)
      8.41%
      Buyback program · as of Oct 28, 2025
      Authorized
      $150.00M
      Spent (derived)
      Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1287865 CUSIP 58463J304 13F (30d) 446 filings 439 filers Visit website Investor relations